Cancer News


Targeted therapies for cancer have the potential for improved in treatment outcome and significant reduced in treatment cost. Identification and functional analysis of genetic mutations specific to certain type of tumor facilitate more effective treatment for cancer patient. One example is using KRAS mutation as an essential biomarker for predicting treatment in patients with non-small-cell lung cancer and colorectal cancer. Conventional techniques for identifying mutation involve intricate, laborious processes as well as expensive instrumentation. In this article, scientists represent a novel technology that offer simple, time-effective and inexpensive method for detecting point of mutations.

For more information, find at

Post Rating


There are currently no comments, be the first to post one.

Post Comment

Only registered users may post comments.



SCI - Events

Stem Cell News

Cell Therapy News

Cancer News

Internship Program